| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
177,680,000 |
| Market
Cap: |
7.94(B) |
| Last
Volume: |
1,420,394 |
Avg
Vol: |
1,949,015 |
| 52
Week Range: |
$44.82 - $99.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 568 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,762 |
108,398 |
166,494 |
290,334 |
| Total Sell Value |
$463,948 |
$6,570,910 |
$11,277,891 |
$18,676,003 |
| Total People Sold |
8 |
10 |
11 |
11 |
| Total Sell Transactions |
11 |
52 |
61 |
100 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Coward D Scott |
Chief Administrative Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,025 |
8,091 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,575 |
808,959 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-03-01 |
4 |
AS |
$137.44 |
$220,316 |
D/D |
(1,603) |
42,989 |
|
-15% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-03-01 |
4 |
AS |
$136.79 |
$776,983 |
D/D |
(5,673) |
3,066 |
|
-15% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-03-01 |
4 |
OE |
$44.37 |
$185,245 |
D/D |
4,175 |
7,241 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-03-01 |
4 |
AS |
$136.79 |
$4,283,387 |
D/D |
(31,293) |
788,384 |
|
-15% |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-03-01 |
4 |
AS |
$137.44 |
$150,909 |
D/D |
(1,098) |
72,206 |
|
-15% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-03-01 |
4 |
AS |
$136.79 |
$1,150,486 |
D/D |
(8,403) |
40,198 |
|
-15% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,263 |
44,592 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,263 |
4,564 |
|
- |
|
| Wyzga Michael S |
Director |
– • – |
2021-02-26 |
4 |
AS |
$130.11 |
$2,474,822 |
D/D |
(19,021) |
2,558 |
|
-14% |
|
| Wyzga Michael S |
Director |
– • – |
2021-02-26 |
4 |
OE |
$26.98 |
$272,714 |
D/D |
10,108 |
21,579 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,312 |
819,677 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,357 |
73,304 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,437 |
48,601 |
|
- |
|
| Doyle James Edward |
Director |
– • – |
2021-02-26 |
4 |
AS |
$130.11 |
$260,220 |
D/D |
(2,000) |
30,459 |
|
-14% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-25 |
4 |
AS |
$132.96 |
$902,532 |
D/D |
(6,788) |
1,301 |
|
-10% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-02-24 |
4 |
AS |
$136.30 |
$606,399 |
D/D |
(4,449) |
45,164 |
|
-10% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-24 |
4 |
AS |
$136.30 |
$826,251 |
D/D |
(6,062) |
8,089 |
|
-10% |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-24 |
4 |
AS |
$136.30 |
$2,238,046 |
D/D |
(16,420) |
810,365 |
|
-10% |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-02-24 |
4 |
AS |
$136.30 |
$280,369 |
D/D |
(2,057) |
70,947 |
|
-10% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-02-24 |
4 |
AS |
$136.30 |
$796,265 |
D/D |
(5,842) |
41,329 |
|
-10% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,300 |
49,613 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-23 |
4 |
AS |
$136.51 |
$2,559,563 |
D/D |
(18,750) |
14,151 |
|
-11% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-23 |
4 |
OE |
$0.00 |
$406,500 |
D/D |
31,600 |
32,901 |
|
- |
|
957 Records found
|
|
Page 13 of 39 |
|
|
0.88 (1.93%) 
